Goldman Sachs
SFE

Goldman Sachs’s Safeguard Scientifics, Inc. SFE Stock Holding History

Goldman Sachs’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,537
Closed -$190K – 6595
2021
Q2 		$190K Sell
24,537
-2,780
-10% -$19K ﹤0.01% 5761
2021
Q1 		$186K Buy
27,317
+7,923
+41% +$57.5K ﹤0.01% 5674
2020
Q4 		$124K Sell
19,394
-39,737
-67% -$248K ﹤0.01% 5253
2020
Q3 		$324K Sell
59,131
-16,133
-21% -$96.3K ﹤0.01% 4693
2020
Q2 		$527K Buy
75,264
+51,469
+216% +$326K ﹤0.01% 4352
2020
Q1 		$132K Sell
23,795
-39,396
-62% -$352K ﹤0.01% 4871
2019
Q4 		$694K Buy
63,191
+19,452
+44% +$222K ﹤0.01% 4333
2019
Q3 		$496K Buy
43,739
+3,027
+7% +$36.1K ﹤0.01% 4458
2019
Q2 		$491K Buy
40,712
+10,578
+35% +$124K ﹤0.01% 4412
2019
Q1 		$327K Buy
30,134
+2,679
+10% +$27.2K ﹤0.01% 4592
2018
Q4 		$237K Sell
27,455
-64,210
-70% -$560K ﹤0.01% 4748
2018
Q3 		$857K Sell
91,665
-6,336
-6% -$68.8K ﹤0.01% 4132
2018
Q2 		$1.25M Buy
98,001
+49,475
+102% +$638K ﹤0.01% 3929
2018
Q1 		$594K Buy
48,526
+21,863
+82% +$266K ﹤0.01% 4379
2017
Q4 		$299K Buy
26,663
+12,458
+88% +$160K ﹤0.01% 5179
2017
Q3 		$190K Sell
14,205
-209
-1% -$2.58K ﹤0.01% 5784
2017
Q2 		$172K Sell
14,414
-922
-6% -$10.9K ﹤0.01% 5877
2017
Q1 		$195K Buy
15,336
+1,754
+13% +$22.1K ﹤0.01% 5745
2016
Q4 		$183K Sell
13,582
-15,997
-54% -$197K ﹤0.01% 5826
2016
Q3 		$383K Buy
+29,579
New +$392K ﹤0.01% 5286
2016
Q2 		– Sell
-10,878
Closed -$144K – 7307
2016
Q1 		$144K Buy
+10,878
New +$137K ﹤0.01% 5861
2015
Q4 		– Sell
-51,344
Closed -$798K – 7396
2015
Q3 		$798K Buy
+51,344
New +$922K ﹤0.01% 4692
2015
Q2 		– Sell
-12,564
Closed -$227K – 7481
2015
Q1 		$227K Sell
12,564
-2,947
-19% -$54.5K ﹤0.01% 5903
2014
Q4 		$307K Sell
15,511
-5,694
-27% -$110K ﹤0.01% 5747
2014
Q3 		$390K Buy
21,205
+909
+4% +$17.9K ﹤0.01% 5501
2014
Q2 		$422K Sell
20,296
-1,307
-6% -$26.3K ﹤0.01% 5472
2014
Q1 		$479K Buy
21,603
+5,420
+33% +$108K ﹤0.01% 5319
2013
Q4 		$325K Sell
16,183
-64
-0.4% -$1.13K ﹤0.01% 5637
2013
Q3 		$255K Sell
16,247
-21,100
-56% -$325K ﹤0.01% 5684
2013
Q2 		$600K Buy
+37,347
New +$594K ﹤0.01% 4786

Other funds holding SFE

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
CCM
Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Goldman Sachs's SFE Position: Q3 2021 in Review

Goldman Sachs sold out of Safeguard Scientifics, Inc. (SFE) in Q3 2021, closing a stake of 24,537 shares — an estimated $190K sold.

Goldman Sachs first reported a position in SFE in Q2 2013 and held it in 30 quarters. The position peaked at $1.25M in Q2 2018. 70 funds tracked by Wall St. Rank hold SFE as of Q3 2021.

  • Goldman Sachs reported no remaining Safeguard Scientifics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 24,537 Safeguard Scientifics, Inc. shares in Q3 2021, an estimated $190K.
  • Goldman Sachs first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 30 quarters.
  • Goldman Sachs's Safeguard Scientifics, Inc. position peaked at $1.25M in Q2 2018.
  • 70 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.